Our Milestones

    A journey of excellence, innovation, and unwavering commitment to pharmaceutical manufacturing.

    1988

    Foundation

    Incorporation of Revat Laboratories Private Limited

    2001

    Incorporation

    Incorporation of the company as Sai Parenteral's Private Limited

    2016

    Ownership Change

    Change in the ownership of the company by acquisition of 100% Equity Shares by existing Promoters

    2021

    Technology Upgrade

    Introduction of Prefilled technology in Sterile Injections Plant

    2022

    Expansion & Growth

    • Acquired TGA Australia Plant from Reichindia Pharma Limited.
    • First R&D Center Setup at Unit 3 for CDMO
    • Achieved a turnover of ₹1,000 million
    2023

    Strategic Acquisitions

    • Acquired PICS Approved Cephalosporin Plant from Medreich Limited
    • First full year of operation of Export and CDMO business
    2024

    Subsidiary Acquisition

    Acquired 100% shareholding of Revat Laboratories Private Limited, pursuant to which it became a wholly owned subsidiary of our Company

    2025

    Global Expansion

    • Incorporation of a wholly owned subsidiary Sai Parenterals Pte. Limited in Singapore
    • Acquisition of 74.6% Stake in Noumed Pharmaceuticals Pty Limited, Australia
    • Approval for 69 Dossiers from FDA, Philippines